Patent Law Basics: 5 Concepts Every Scientist Should Know

Every scientist needs to understand the basics of patent law. At some point in your career, you’ll read someone else’s patent—either to figure out what’s actually protected or to identify gaps and design-around opportunities. And sooner or later, you’ll be involved in your own company’s filings. You may be asked to generate supporting data, write up experimental results, or draft sections of an application—all to help secure the extremely valuable exclusivity that patents can provide.

This post is a quick primer on five concepts that cause the most confusion (and the most avoidable mistakes). If you understand these, you’ll read patents faster, communicate more clearly with counsel, and avoid landmines like disclosing before filing. You don’t need to become a patent agent or attorney—just learn the handful of rules that drive how patent rights are actually won and enforced.

1. Application vs Patent (they are not the same thing)

• Patent application: The document the inventor/applicant files. It describes the invention broadly (often a “best-case” or “dream scenario”), including lots of options the applicant wants to protect, not what’s enforceable.
• Patent (issued/granted): The version that has been examined and allowed by the patent office. The claims in an issued patent are what’s enforceable.

Why it matters: A huge number of “patents” you find online are published applications, not issued patents. In the U.S., look at the top left-hand corner to see “Patent Application Publication” or “United States Patent”. If you treat an application like an issued patent, you’ll overestimate what the company actually owns. The scope usually shrinks during prosecution. 

Pro tip: If it’s a U.S. case, check the prosecution history (a.k.a. file wrapper) to see how the claims were amended and what the examiner forced them to give up. That’s often where the real story is. Google “USPTO Patent File Wrapper” or “USPTO Global Dossier”—access to these documents is open to the public.

2. Provisional vs Non-Provisional Application (what they are and why you should care)

• Provisional application: A placeholder filing that lets an applicant secure an early priority date (defined below) for what is actually described in the application. It is not examined and cannot become a patent by itself.
• Non-provisional application: Yes, it’s a confusing name. This is the real patent application (in the U.S.) that gets examined by the patent office. It’s the application that can mature into an issued patent, and it’s where the claims ultimately get negotiated. 

Why it matters: After filing a provisional, the applicant has 12 months to file a non-provisional application that claims priority to that provisional. If they miss that deadline, they lose the benefit of the provisional’s filing date.

Pro tip: Scientists often hear “we filed a patent” and assume the invention is “protected.” In many cases, what was actually filed was a provisional application. What you really have is a date—not an enforceable patent. And that date only covers what the provisional actually discloses. If you improve the invention later and only describe those improvements in the non-provisional that were not in the provisional, those additions do not get the provisional priority date—they get the later non-provisional filing date.

3. Filing Date vs Priority Date (which one matters more?)

• Filing date: The date the specific document you’re reading was filed (e.g., the non-provisional application that later issued).
• Priority date: The earlier filing date the application claims benefit to—usually a provisional application or an earlier non-provisional in the same family. This is the date that often matters most for “who was first” in the prior art timeline.

Why it matters: When you’re evaluating prior art, novelty, or freedom-to-operate, what usually counts is the earliest valid priority date—because that’s the timestamp that can block later publications/patents from counting against the claims (and vice versa).

Extra Nuance:

A patent can claim priority to an earlier filing date, but only for what was actually disclosed in that earlier application. If the claims rely on material that first appears later, the “effective” priority date for those claims can be later too.

Pro tip: Open any U.S. patent PDF and look at the first page:

• “Filed:” – that’s the filing date of the application that ultimately became the published application/issued patent you’re viewing.
• “Related U.S. Application Data” – this is where you’ll see earlier applications (provisionals or parent applications) and their filing dates. The earliest of those dates is often the priority date.

4. Prior Art (the universe the patent application must beat)

• Prior art (the what): Any publicly available information that can be used to challenge whether a claim is new or non-obvious—patents and published applications, scientific papers, technical white papers, posters/presentations, product labels/manuals, and even the public use or sale of an invention.
• Prior art (the when): Prior art is defined by timing. In general, it’s information that existed before the patent application was filed—more specifically, before the application’s priority date, which can be earlier than the filing date (see Filing date vs. Priority date above).
• Secret prior art: Prior art that wasn’t public at the time you filed, but can still be used against you because it was filed earlier and later becomes public (for example, an earlier-filed patent application that publishes later). In other words: it was “secret” on your filing date, but it can still count as prior art once it publishes.

Why it matters: Prior art is the universe your patent application must “beat.” If prior art already discloses what you’re trying to claim, you’ll get a novelty rejection. If it strongly suggests your claim as an expected next step, you’ll get an obviousness rejection (see the Novelty and Obviousness section below).

Pro tip: Prior art includes your own disclosures. Poster presentations, theses, and slide decks can all be used against you if they become public before you file. And it doesn’t matter if you weren’t the one who “leaked” it—once it’s public, it can still count as prior art.

5. Novelty and Obviousness (how claims get rejected)

• Novelty (anticipation): The claim must be new. If a single prior art reference discloses every element of the claim, it’s not novel (a “102 rejection”).
• Obviousness: The claim must not be an obvious variation of what was already disclosed in the prior art. Even if no single reference discloses the whole claim, the claim can still be rejected if it would have been a predictable modification or combination of prior art (a “103 rejection”).

Why it matters: These are the two biggest “substantive” hurdles during prosecution of a patent application. Novelty knocks out claims that are already disclosed. Obviousness knocks out claims that are new on paper but viewed as an expected next step to someone skilled in the field. And as you can imagine, obviousness can be fuzzy—most patent prosecution revolves around negotiating what is obvious and what is not.

Illustrative example 1 (novelty)

• Issued patent A: claims drug X + excipient Y + excipient Z
• Patent application B: claims drug X + excipient Z
• Response: Novelty (“102”) rejection. Patent A discloses every element of the claim in application B (X and Z). The fact that Patent A also includes Y doesn’t avoid anticipation, because the claim in application B doesn’t exclude Y—it just doesn’t require it.
• Argument: Your only real paths are (1) show the examiner is wrong about what the reference discloses, or (2) amend the claim to add a limitation that isn’t in Patent A. There usually isn’t a persuasive “it’s still novel” argument if the reference truly contains every element.

Illustrative example 2 (obviousness)

• Issued patent A: claims drug X + excipient Y
• Issued patent B: claims drug X + excipient Z
• Patent application: claims drug X + excipient Y + excipient Z
• Response: Obviousness (“103”) rejection is a common scenario. The examiner argues that someone skilled in the field would have been motivated to combine the teachings of A and B to arrive at X with both Y and Z, and would have had a reasonable expectation it would work (i.e., it’s a predictable combination).

Argument: Applicants often rebut an obviousness/ 103 rejection by arguing the combination wasn’t actually predictable (e.g., incompatibility, instability, unexpected results, or no good reason to combine).